Nasus Pharma Ltd (NSRX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-13
09:29 am
Purchase
2025-09-3013GNasus Pharma Ltd.
NSRX
Dr. Ronnie Hershman1,383,512
15.300%
1,383,512increase
(New Position)
Filing
History
2025-11-12
4:05 pm
Purchase
2025-09-3013GNasus Pharma Ltd.
NSRX
Dr. Dalia Megiddo1,888,873
20.900%
1,888,873increase
(New Position)
Filing
History
2025-11-10
5:05 pm
Purchase
2025-09-3013GNasus Pharma Ltd.
NSRX
Udi Gilboa1,901,311
21.100%
1,901,311increase
(New Position)
Filing
History
2025-08-20
4:55 pm
Purchase
2025-08-1413GNasus Pharma Ltd.
NSRX
Capital Point Ltd.575,129
6.350%
575,129increase
(New Position)
Filing
History